Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study
Pain Medicine · 04.08.2026
DOI: 10.1093/pm/pnag100 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pain Medicine, online erschienen am 04.08.2026. Verfasst von Paloma L Aveni-Strafile und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology & Perioperative Medicine. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Objectives
To evaluate the incidence and risk factors of chronic opioid use following head and neck adenoid cystic carcinoma (HNACC) surgery and explore the association between postoperative opioid use and survival outcomes.
Design
Observational retrospective cohort study. Settings Perioperative care of cancer patients at the University of Texas—MD Anderson Cancer Center. Subjects Adults (≥18 years) who underwent HNACC surgery with curative intent were included; while those with recurrent or metastatic disease at the time of surgery or who received palliative treatment were excluded.
Methods
Multivariable logistics and Cox regression analyses were performed to identify predictors of chronic opioid use and explore associations with recurrence-free survival (RFS) and overall survival (OS). Chronic opioid use was defined as an active opioid prescription documented and reconciled by a clinician on postoperative day 90 (POD90).
Results
Among 102 subjects included in the study, 47.1% were taking opioids chronically after surgery. Preoperative opioid use was associated with more than double the odds of chronic postoperative opioid use, whereas older age and ASA class 1-2 were associated with reduced odds. Positive surgical margins, bone graft procedures, and neck dissection were independently associated with poorer prognosis. No statistically significant association between opioid use an RFS and OS was observed.
Conclusions
These findings suggest that patients with HNACC exhibit several risk factors for chronic opioid use, underscoring the importance of careful opioid prescribing and monitoring in this population.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Anesthesiology & Perioperative Medicine. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA.
- Anesthesiology and Surgical Oncology Research Group. Houston, Texas, USA.
- Department of Pain Medicine. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA.
- Department of Biostatistics. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA.
- Thoracic/Head & Neck Medical Oncology. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA.
- Head & Neck Surgery. The University of Texas MD Anderson Cancer Center. Houston, Texas, USA.
Förderung
- National Institutes of Health
Zitieren
APA
Aveni-Strafile, P. L., Cortes-Mejia, N. A., Sah, D. K., Cao, J., Feng, L., Wachter, E. S., Ferrarotto, R., Sikora, A., Williams, M., Lei, Y. L., & Cata, J. P. (2026). Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study. Pain Medicine. https://doi.org/10.1093/pm/pnag100
Vancouver
Aveni-Strafile PL, Cortes-Mejia NA, Sah DK, Cao J, Feng L, Wachter ES, et al. Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study. Pain Medicine. 2026. doi:10.1093/pm/pnag100
BibTeX
@article{AveniStrafile2026,
author = {Aveni-Strafile, Paloma L and Cortes-Mejia, Nicolas A and Sah, Dhananjay K and Cao, Jinwen and Feng, Lei and Wachter, Emilia Scalco and Ferrarotto, Renata and Sikora, Andrew and Williams, Michelle and Lei, Yu Leo and Cata, Juan P},
title = {Postoperative opioid use and survival outcomes in patients with head and neck adenoid cystic carcinoma. A retrospective study},
journal = {Pain Medicine},
year = {2026},
doi = {10.1093/pm/pnag100}
}
EUVIMED